Oncology Development Built Around Biotech Innovation
Modern oncology development is defined by biomarker-driven science, adaptive trial design, precision medicine approaches and evolving regulatory pathways. Delivering these programs well requires integrated scientific expertise and collaborative partnership from the same team throughout the lifecycle.
Evestia Clinical provides integrated scientific partnership that preserves program knowledge and continuity from first-in-human studies through registration. As a Biotech CRO, that partnership is available through scalable Full-Service CRO delivery and embedded FSP capability that evolves alongside program needs.
Experienced Oncology Medical Specialists
Hands-on Phase I–IV & Post-Marketing expertise across solid tumors, hematological malignancies, immuno-oncology, precision medicine and advanced therapies.
Senior Clinical Leadership Access
Direct access to senior oncology leadership throughout program delivery, providing continuity of scientific knowledge and experienced decision-making at every milestone.
Integrated Scientific Expertise
Clinical Operations, Medical Affairs, Regulatory Affairs, Biostatistics, Data Management, Medical Writing and Pharmacokinetics working within one coordinated oncology team.
Flexible Delivery Models
Full-Service CRO or embedded FSP specialists, scaled to program stage with the scientific depth and operational continuity complex oncology programs require.
Oncology Expertise at a Glance
Behind these figures is the accumulated experience that shapes every program decision, from biomarker strategy and site selection to regulatory submissions and safety monitoring. This expertise spans full-service clinical delivery, Functional Service Provider (FSP) support and strategic consulting, strengthened through the acquisition of ICRC-Weyer, with end-to-end product lifecycle support from first-in-human studies through post-marketing.
300+
Oncology Studies Supported
Across multiple tumor types and development phases
63%
Team with Oncology Expertise
Specialist oncology experience
50+
Cell & Gene Therapy Studies
Advanced therapies and ATMPs
25+ Years
Clinical Research Experience
Supporting complex oncology programs
Specialist Oncology Clinical Development Expertise Across Complex Cancer Programs
Modern oncology development demands scientific expertise, regulatory planning and operational delivery working within one integrated structure. Coordinated oncology expertise supports scientific consistency, multidisciplinary program leadership and accountable delivery across every stage of development.
Clinical Operations, Medical Affairs, Regulatory Affairs, Clinical Data Management and Biostatistics work within the same program governance structure, providing a single accountable scientific partner across more than 300 oncology studies and 25 years of clinical research experience spanning solid tumors, hematological malignancies, rare cancers and advanced therapies.
Why Oncology Clinical Development Requires Specialist Expertise
Precision medicine, biomarker strategy, adaptive trial design, specialist investigator networks and accelerated regulatory pathways define modern oncology development. Each requires deep scientific understanding and experienced program leadership to deliver well.
Across Phase I, Phase II and Phase III development, scientific leadership and collaborative oncology expertise build program confidence at every milestone.
Oncology Expertise Built Around Complex Clinical Development
Modern oncology development requires expertise across biomarkers, precision medicine, adaptive trial design and evolving regulatory pathways. Targeted therapies, immunotherapies, antibody-drug conjugates and cellular approaches each bring distinct scientific and operational demands that benefit from integrated, oncology-focused program leadership.
Oncology is one of Evestia Clinical's core therapeutic focuses. Through alignment of Clinical Trial Management, Medical Affairs, Regulatory Affairs and Clinical Data Management, sponsors gain an integrated delivery model that maintains scientific consistency from protocol development through submission.
Why Oncology Clinical Trials Require Specialist Expertise
Modern oncology programs commonly involve:
Across more than 300 oncology studies, these program requirements have been addressed through integrated scientific expertise, supporting confident program progression at every stage of development.
Oncology Clinical Trial Services
Oncology programs depend on clinical disciplines working in alignment. Each service below is delivered within one coordinated team, supporting scientific consistency, operational excellence and program confidence throughout development.
Clinical Trial Management
Delivering operational leadership and program oversight across complex oncology studies from initiation through to study close-out.
Learn moreClinical Operations
Integrated clinical operations support coordinating investigators, sites, vendors and study activities throughout the oncology development lifecycle.
Learn moreClinical Monitoring
Specialist oncology monitoring support focused on protocol compliance, patient safety and data integrity across all study sites.
Learn moreClinical Site Management
Supporting high-performing oncology investigator sites through activation, engagement and performance management throughout the study.
Learn moreStudy Start-Up Services
Efficient site feasibility, selection and activation strategies to accelerate oncology study timelines from protocol development to first patient enrolled.
Learn moreRegulatory Affairs
Helping sponsors navigate global regulatory requirements and oncology-specific submission strategies for FDA, EMA, MHRA and other health authorities.
Learn moreClinical Data Management
Managing complex oncology datasets, biomarkers, integrated data sources and CDISC-compliant outputs for regulatory submissions.
Learn moreBiostatistics
Supporting study design, endpoint analysis, survival modeling, adaptive designs and regulatory reporting across oncology programs.
Learn morePharmacovigilance
Providing comprehensive safety oversight, adverse event management and signal detection across oncology development programs.
Learn moreMedical Writing
Preparing protocols, investigator brochures, clinical study reports and regulatory documentation for oncology submissions.
Learn moreMedical Affairs
Physician-led medical monitoring, medical strategy and safety review providing therapeutic expertise throughout oncology development.
Learn morePharmacokinetics
Supporting exposure-response analyzes, PK modeling and dose optimization strategies tailored to oncology development programs.
Learn moreFSP Solutions
Dedicated embedded oncology specialists available through our Functional Service Provider model for sponsors requiring flexible resource scaling.
Learn moreExpertise Across Oncology Modalities
Solid Tumors
Supporting clinical development across a broad range of solid tumor indications including lung, breast, colorectal, prostate, ovarian and gastrointestinal cancers.
Hematological Malignancies
Experience supporting studies involving leukemia, lymphoma, multiple myeloma and other blood cancers across early and late-phase development.
Immuno-Oncology
Supporting innovative immunotherapy programs including checkpoint inhibitors, combination therapies and novel immune-based approaches across multiple tumor types.
Precision Medicine
Helping sponsors develop biomarker-driven therapies through integrated operational, scientific and regulatory support tailored to molecular targeting approaches.
Cell & Gene Therapy
Supporting advanced therapy programs including CAR-T and other cell-based oncology treatments through our specialist Cell & Gene Therapy expertise.
Learn moreAntibody-Drug Conjugates
Supporting ADC development programs through specialist clinical operations, safety monitoring and regulatory expertise aligned with the unique requirements of these complex biological therapies.
Supporting Oncology Programs from First-in-Human Studies to Regulatory Submission
Each phase introduces distinct priorities: intensive safety monitoring in dose-escalation programs, biomarker-driven patient selection in proof-of-concept studies and multinational regulatory coordination at registration.
The same oncology specialists remain engaged as programs advance, preserving scientific and program context from first-in-human studies through proof-of-concept to registration and post-marketing, with Regulatory Affairs and Clinical Trial Management aligned throughout.
Supporting Precision Oncology and Biomarker-Driven Development
Identifying, enrolling and retaining biomarker-defined populations plays a central role in the success of precision oncology programs. Companion diagnostic co-development, molecular profiling strategies and molecularly defined eligibility criteria require scientific and operational capability working in close alignment throughout development.
Clinical Data Management and Biostatistics specialists manage complex biomarker datasets and ensure analytical strategies align with regulatory expectations, including the AI-enabled analysis and genomic profiling platforms increasingly central to modern oncology data. Regulatory Affairs teams navigate accelerated pathways, companion diagnostic requirements and evolving guidance, while our Cell & Gene Therapy CRO capabilities extend this expertise into CAR-T and other ATMP programs.
Oncology Development Across Every Phase
Phase I Oncology Trials
First-in-human and dose-escalation studies with intensive safety monitoring, access to specialist investigator networks and early biomarker assessments that inform Phase II design.
Learn morePhase II Oncology Trials
Proof-of-concept, dose optimization and efficacy signal evaluation across biomarker-selected and broader patient populations, generating the evidence base that justifies registration investment.
Learn morePhase III Oncology Trials
Multinational registration studies with coordinated site activation, parallel regulatory submissions and submission-ready evidence generation across multiple countries and jurisdictions.
Learn moreHow Evestia Strengthens Oncology Development
Integrated scientific expertise, experienced oncology leadership and coordinated program delivery support confident oncology development across every stage, from first-in-human studies through global regulatory registration.
Biomarker-Driven Recruitment
Companion diagnostic requirements and molecularly defined eligibility criteria require specialist scientific, operational and data expertise to support successful biomarker-driven enrollment. Integrated data management and established oncology investigator relationships address these needs throughout development.
Precision Medicine
Biomarker strategy, genomic data integration and regulatory planning for targeted therapies require integrated scientific, regulatory and operational expertise. These capabilities are embedded within every precision oncology program.
Global Site Networks
Accessing specialist oncology investigators requires established relationships and coordinated governance across regions. Site networks across Europe, North America and other key markets are made available through established international oncology investigator relationships and coordinated program leadership.
Accelerated Development
Fast Track, Breakthrough Therapy Designation and Accelerated Approval pathways each bring distinct regulatory requirements. Navigating them requires regulatory expertise, adaptive program management and coordinated delivery across scientific and operational disciplines.
Rare Oncology Programs
Rare cancers combine oncology complexity with small, dispersed patient populations. Dedicated Oncology and Rare Disease expertise strengthens study design and program delivery for sponsors developing treatments in rare cancer indications.
Scalable Oncology Capability
As oncology portfolios grow, access to scalable clinical expertise becomes a strategic priority. Full-Service CRO delivery and embedded FSP specialists provide the scientific depth and integrated partnership needed at each stage of development.
Rare Cancers and Orphan Oncology Programs
Rare cancer programs combine oncology complexity with the distinct development requirements of small patient populations and dispersed specialist centers. Combined Oncology and Rare Disease expertise supports study design and delivery across:
- Limited patient populations
- Specialist investigator networks
- Complex recruitment strategies
- Global site coordination
- Regulatory incentives
Sponsors developing treatments for rare oncology indications benefit from our combined Oncology, Rare Disease and Orphan Drug Development expertise. Our Global CRO capabilities support access to specialist investigator networks and multinational study delivery for rare cancer programs with geographically dispersed patient populations.
Why Sponsors Choose Evestia Clinical for Oncology Clinical Trials
The oncology CRO a sponsor chooses shapes more than operational execution. It shapes the quality of every scientific decision, the strength of every regulatory submission and the confidence with which a program approaches its most important milestones.
Oncology Knowledge Embedded in Every Program
Deep therapeutic knowledge across solid tumors, hematological malignancies, immuno-oncology, precision medicine and cell and gene therapy, built across more than 300 oncology studies and 25 years of clinical research experience. Scientific partnership embedded throughout program delivery.
Senior Medical Expert Access Throughout Development
Direct access to senior oncology medical specialists throughout program delivery, providing continuity, direct collaboration and experienced oncology leadership at every milestone. Structured to provide the senior-led engagement that complex oncology programs require.
Delivering Global Oncology Programs With Consistent Quality
Established oncology site networks, multinational study delivery expertise and operational presence across key clinical research regions. Sponsors access specialist investigators and coordinate international programs through established international oncology investigator relationships and coordinated program delivery.
Integrated Expertise Supporting Scientific Consistency
Oncology programs supported through an integrated Full-Service CRO model, combining Clinical Operations, Medical Affairs, Regulatory Affairs, Data Management, Biostatistics, Pharmacovigilance and Medical Writing in one coordinated delivery structure. Consistent scientific collaboration across every oncology discipline.
Advanced Therapy Experience
Dedicated Cell and Gene Therapy expertise integrated within oncology development programs, supporting CAR-T, ATMP approaches and precision medicine developments alongside core oncology clinical development capabilities.
An Agile Partner Built Around Patient Outcomes
Operational responsiveness, scientific collaboration and a patient-centred approach to every program decision. From site selection and recruitment strategy through to safety monitoring and regulatory interactions, Evestia Clinical keeps the focus on delivering therapies to the patients who need them.
Flexible Oncology Resource Models That Scale With Programs
Scalable oncology expertise aligned with program needs through Full-Service CRO and embedded FSP delivery, providing dedicated oncology specialists for sponsors who require integrated scientific capability at each stage of development.
Oncology CRO Support for Biotech Companies
Biotechnology companies advancing oncology programs need scalable clinical expertise, integrated scientific partnership and the flexibility to access both at each stage of development. Evestia Clinical provides integrated scientific partnership that grows alongside program needs, from first-in-human studies through to registration.
Biotech sponsors access that capability through our Full-Service CRO model or embedded FSP specialists, from early Phase I through to regulatory submission.
Frequently Asked Questions About Oncology CRO Services
Explore Related Clinical Development Services
Service Pages
Development Phases
Related Therapeutic Expertise
Helping Oncology Innovators Bring New Therapies to Patients
Integrated oncology expertise, scientific leadership and collaborative partnership from first-in-human studies to global registration. Evestia Clinical is the oncology development partner built for biotechnology and pharmaceutical companies advancing programs where scientific rigor and operational excellence matter equally.